Keytruda is the first and only anti-PD-1 therapy approved in combination with chemoradiotherapy for these patients
SyntheticGestalt will develop a pre-trained AI model to discover synthesizable drug-like hit candidates
Launch innovative vitamin sublingual sprays
Ribo's cutting edge RIBO-GalSTAR platform enables the development of RNAi therapeutics targeting disease-causing genes specifically in hepatocytes
The survey data presented in “The State of the Biopharmaceutical Industry 2024” report reveals that N=21 (18%) of industry professionals were convinced that CGT will dominate as the most important trend in pharma next year
Innovent also obtains an exclusive option to license in the future development, manufacturing and commercialization rights of SGB-3908
Elpiscience will receive up to US $37 million, including the upfront payment and license option fees
The establishment of the facility demonstrates the company's commitment to delivering differentiated solutions to gynecology and pediatrics challenges
The LyondellBasell CirculenRenew polymers are made from renewable feedstocks derived from bio-based wastes
Syngene has completed a payment of Rs. 158.2 crores on December 22, 2023 in addition to the initial payment of Rs. 395 crores made on December 1, 2023
Subscribe To Our Newsletter & Stay Updated
